Cannabigerol Synthesis and Sequential Distillation-Extraction Purification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing cannabigerol (CBG) face challenges in achieving high purity due to issues like polyalkylation, selectivity, and the need for costly and time-consuming chromatographic purification methods, which are not addressed in the literature.

Innovation Solution

A method involving the reaction of olivetol with allylic compounds having a leaving group, followed by distillation and liquid-liquid extraction, to selectively separate cannabigerol from regioisomers and other impurities, achieving high purity without chromatographic purification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If chromatographic purification methods are used to purify cannabigerol, then purity is improved, but production cost and time consumption increase

Engineering Contradiction:
ImprovepurityVSAvoidproduction cost and time consumption
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent changes the physical parameters of the reaction system by controlling temperature gradients during distillation and adjusting liquid-liquid extraction phase ratios to achieve high purity CBG separation without chromatographic methods. The distillation process uses specific temperature ranges (60-80°C for initial distillation, 100-120°C for final distillation) to selectively vaporize and condense CBG while leaving impurities behind.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent replaces the mechanical/chromatographic purification system with a thermal distillation system and liquid-liquid extraction system. Instead of using chromatography columns with stationary phases, the invention uses temperature-controlled distillation apparatus and solvent-based extraction, thereby eliminating the need for expensive chromatographic materials and reducing production time.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Productivity

If simple distillation is used for purification, then production cost is reduced, but purity is insufficient

Engineering Contradiction:
Improveproduction costVSAvoidpurity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent divides the purification process into multiple sequential stages: first distillation to remove low-boiling impurities, liquid-liquid extraction to remove intermediate impurities, and second distillation to remove high-boiling impurities. Each stage targets specific types of impurities, progressively increasing purity to >99% without requiring expensive chromatographic methods.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs a composite purification approach combining two different separation mechanisms: distillation (based on volatility differences) and liquid-liquid extraction (based on solubility differences). This composite method leverages the complementary strengths of both techniques to achieve high purity removal of diverse impurity types that would be difficult to eliminate with a single method.

Inventive Principle:
Principle #40Composite materials

3Productivity

If Friedel-Crafts alkylation is used to synthesize cannabigerol, then production efficiency is improved, but polyalkylation side reactions occur reducing selectivity

Engineering Contradiction:
Improveproduction efficiencyVSAvoidselectivity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent introduces a preliminary step before the main Friedel-Crafts alkylation reaction: converting olivetol to its methyl ether derivative. This preliminary protection of the phenolic hydroxyl group prevents it from participating in unwanted side reactions and directs the alkylation to occur only at the desired aromatic ring position, thereby improving selectivity while maintaining production efficiency.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses a methyl ether intermediate as a mediator in the synthesis pathway. The methyl ether group acts as a temporary protecting group that modulates the reactivity of olivetol during the Friedel-Crafts reaction, ensuring selective alkylation at the correct position. After the alkylation is complete, the methyl ether is removed to yield the final CBG product with high selectivity.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for the production of cannabigerol in purity greater than 99% efficiently and cost-effectively, overcoming the limitations of previous methods by enhancing selectivity and reducing the need for chromatographic techniques.

Implementation Method 1

purifying the product by distillation

Methodology Applied
Scientific EffectDistillation: Distillation

Implementation Method 2

reacting olivetol with one or a mixture of two or more allylic compound(s) having a leaving group in the presence of an acidic or lewis acidic catalyst

Methodology Applied
Scientific EffectFriedel-Crafts alkylation: Chemical Bonding

Data Source

PatentEP3983367B1Synthesis and purification of cannabigerol and its application
Publication Date: 2025.07.30 SYMRISE GMBH & CO KG
  • EP3983367B1 patent drawingFigure 1
  • EP3983367B1 patent drawingFigure 2
  • EP3983367B1 patent drawingFigure 3

AI summary

The present invention relates to a method for producing cannabigerol and purifying it from a reaction mixture. The present invention also relates to the cosmetic use of cannabigerol for the inhibition of tyrosinase activity and/or the reduction of melanin production in the skin, in particular for reducing pigmentation of the skin, preferably for the improvement of the appearance of the skin in case of hyperpigmentation, lentigo or vitiligo. Furthermore, the present invention relates to cannabigerol for use in a therapeutic method for the inhibition of tyrosinase activity and/or the reduction of melanin production in the skin, preferably for use in a therapeutic method for the treatment and/or prevention of malign skin disorders, in particular skin cancer.